Protagonist Therapeutics Inc (NASDAQ:PTGX)
| 10.43 BATS BZX Real-Time Price As of 1:06pm ET |  -0.40 / -3.69%Today’s Change | 6.91 Today|||52-Week Range 50.54 | -69.50% Year-to-Date |
Latest PTGX News | Press Releases
| How Much Upside is Left in Protagonist Therapeutics (PTGX)? Wall Street Analysts Think 302% Aug 10 / Zacks.com - Paid Partner Content | Protagonist Therapeutics (PTGX) Reports Q2 Loss, Misses Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 10.83 |
| Today’s open | 10.72 |
| Day’s range | 10.27 - 10.81 |
| Volume | 15,784 |
| Average volume (3 months) | 1,302,453 |
| Market cap | $559.6M |
Data as of 1:06pm ET, 08/17/2022
Growth & Valuation
| Earnings growth (last year) | -40.93% |
| Earnings growth (this year) | -14.23% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -4.44% |
| P/E ratio | NM |
| Price/Sales | 57.91 |
| Price/Book | 1.82 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VXRTVaxart Inc | -0.07 | -1.68% |
| HRTXHeron Therapeutics I... | -0.17 | -3.15% |
| BLUEbluebird bio Inc | -0.37 | -5.62% |
| ACETAdicet Bio Inc | +0.06 | +0.43% |
Data as of 1:07pm ET, 08/17/2022
Financials
| Next reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$0.94 |
| Annual revenue (last year) | $27.4M |
| Annual profit (last year) | -$125.6M |
| Net profit margin | -458.94% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Newark, California |
Forecasts
